3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
7
Phase NA
5
Phase 1/2
3
Phase 2
2
Phase EARLY_PHASE1
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Papillomavirus Infections
1
Interventions
Magnetic Resonance Spectroscopy
23
Metformin
14
pembrolizumab
12
Radiotherapy
12
Biopsy
11
Nivolumab
9
Fluorouracil
9
Cyclophosphamide
9
Temozolomide
7
Radiation
7
Bevacizumab
7
gallium 68 PSMA-11
6
Sirolimus
6
Rituximab
6
Letrozole
6
Etoposide
6
Cisplatin
6
Aspirin
6
olaparib
5
Surveys and Questionnaires
5
Radiosurgery
5
Oxaliplatin
5
Irinotecan
5
Indocyanine Green
5
Granulocyte Colony-Stimulating Factor
5
Fluorodeoxyglucose F18
5
Dexamethasone
5
aldesleukin
4
Surgical Procedures, Operative
4
Proflavine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Completed
×
Receptor Protein-Tyrosine Kinases
×
Clear all
NCT01588301
2014-09-12
APACHE-2
University Hospital, Tours
Phase EARLY_PHASE1
Completed
5,998 enrolled